☆ 3.8 Article

Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Biochemistry & Molecular Biology

The acid sphingomyelinase/ceramide system in COVID-19

Johannes Kornhuber et al.

Summary: ASM cleaves sphingomyelin into ceramide, which SARS-CoV-2 uses for cell entry. Lowering ceramide levels or blocking its action can protect cells against infection. Several clinically approved drugs that inhibit ASM have shown beneficial effects against COVID-19.

MOLECULAR PSYCHIATRY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro

Senem Merve Fred et al.

Summary: Repurposing currently available drugs is a valuable strategy against the consequences of COVID-19. A study tested the inhibitory effects of various antidepressants and antipsychotic drugs on SARS-CoV-2 and its variants, finding that some of these drugs were effective in inhibiting viral infection with minimal impact on cell viability.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Psychiatry

Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study

Nicolas Hoertel et al.

Summary: The study found that the use of FIASMA psychotropic medications may reduce the risk of intubation or death in COVID-19 patients. Especially, patients taking FIASMA antidepressants have a lower risk compared to those taking non-FIASMA antidepressants. These findings are important for further evaluating the effectiveness of FIASMA medications against COVID-19.

TRANSLATIONAL PSYCHIATRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

Quan Qiu Wang et al.

Summary: This study identified individuals with SUD, especially those with OUD and African Americans, as having an increased risk for COVID-19 and worse outcomes. Screening and treating individuals with SUD is crucial in controlling the pandemic and ensuring healthcare support without disparities.

MOLECULAR PSYCHIATRY (2021)

添加到收藏夹

Article Psychiatry

Increased risk ofCOVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States

QuanQiu Wang et al.

Summary: Patients recently diagnosed with mental disorders are at increased risk for COVID-19 infection, especially those with depression and schizophrenia. Additionally, there are disparities in infection risk among African Americans and women, suggesting the need for targeted interventions to address these vulnerabilities.

WORLD PSYCHIATRY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: A multicentre retrospective observational study

Nicolas Hoertel et al.

Summary: In this multicentre observational study, dexamethasone use at a cumulative dose between 60 mg and 150 mg was associated with reduced mortality among patients with COVID-19 requiring respiratory support.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19

Nicolas Hoertel et al.

Summary: The study found that the use of chlorpromazine in COVID-19 patients was not significantly associated with reduced mortality rates. Multiple sensitivity analyses confirmed these results, indicating no clear benefit in reducing mortality.

CLINICAL DRUG INVESTIGATION (2021)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Impact of the timing and adherence to face mask use on the course of the COVID-19 epidemic in France

Nicolas Hoertel et al.

JOURNAL OF TRAVEL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

Nicolas Hoertel et al.

Summary: This study suggests that the use of antidepressants in patients hospitalized for COVID-19 may be associated with a lower risk of death or intubation. Antidepressants such as fluoxetine, paroxetine, escitalopram, venlafaxine, and mirtazapine showed significant associations with reduced risk. Further research in the form of double-blind controlled randomized clinical trials is recommended.

MOLECULAR PSYCHIATRY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Observational study of haloperidol in hospitalized patients with COVID-19

Nicolas Hoertel et al.

Summary: The study found that the use of haloperidol at an average dose of 4.5 mg per day for an average duration of 8.4 days may not be associated with risks of intubation or death, or with time to discharge among adult patients hospitalized for COVID-19.

PLOS ONE (2021)

添加到收藏夹

Article Psychiatry

A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders

Ahmad A. Toubasi et al.

Summary: This meta-analysis found that pre-diagnosis with mental disorders is associated with an increased risk of COVID-19 mortality and severity. Patients with schizophrenia, schizotypal, and delusional disorders had higher mortality rates compared to those with mood disorders. It is recommended to prioritize vaccination for patients with mental disorders alongside healthcare providers and the elderly.

PSYCHIATRY RESEARCH (2021)

添加到收藏夹

Article Psychiatry

Association of Psychiatric Disorders With Mortality Among Patients With COVID-19

Katlyn Nemani et al.

Summary: The study found that patients with schizophrenia spectrum disorders were significantly associated with mortality in COVID-19 cases, while patients with mood disorders and anxiety disorders were not.

JAMA PSYCHIATRY (2021)

添加到收藏夹

Article Immunology

Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19

David Seftel et al.

Summary: In this study, 65 individuals opted to receive fluvoxamine for COVID-19 treatment, with a 0% hospitalization rate and 0% residual symptoms. In comparison, 48 individuals who chose observation alone had a hospitalization rate of 12.5% and residual symptoms in 60% of cases. This suggests that fluvoxamine may help alleviate the severity and duration of COVID-19.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Microbiology

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro

Arthur Dechaumes et al.

Summary: Fluoxetine (FLX) has shown potential to inhibit SARS-CoV-2 in vitro, suggesting its value in further research as a potential anti-viral treatment option against SARS-CoV-2 infections.

MICROORGANISMS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study

Gil Darquennes et al.

Summary: This study investigated the impact of functional inhibitors of acid sphingomyelinase (FIASMAs) on in-hospital COVID-19 mortality, finding a significant association between chronic use of amlodipine and low mortality rates in COVID-19 inpatients.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Psychiatry

Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients

Crisanto Diez-Quevedo et al.

Summary: The study found that mental disorders are common in COVID-19 patients and that receiving psychopharmacological treatments may affect mortality rate. Therefore, timely detection and treatment of mental disorders are crucial for the prognosis and functional recovery of the disease.

ACTA PSYCHIATRICA SCANDINAVICA (2021)

添加到收藏夹

Article Psychiatry

Mood Disorders and Outcomes of COVID-19 Hospitalizations

Victor M. Castro et al.

Summary: The study found that COVID-19 patients with a history of mood disorders may face increased risk of morbidity and mortality in the hospital, as well as a higher likelihood of needing post-acute care. Further research should investigate the mechanisms by which these disorders may contribute to elevated risk.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Melissa Zimniak et al.

Summary: Research has found that Fluoxetine can effectively inhibit SARS-CoV-2 infection and show activity in human lung tissue. Both stereoisomers of Fluoxetine exhibit similar activity against the virus, with the R-form possibly being specifically used for SARS-CoV-2 treatment.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

Vikas P. Sukhatme et al.

Summary: Fluvoxamine, a well-tolerated and widely available selective serotonin reuptake inhibitor, has shown potential in preventing clinical deterioration of COVID-19 patients in a small study. It functions through various mechanisms such as antiviral effects, anti-inflammatory properties, and regulation of coagulopathy.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Medical Informatics

Hybrid Deep Learning for Medication-Related Information Extraction From Clinical Texts in French: MedExt Algorithm Development Study

Jordan Jouffroy et al.

Summary: The study aimed to develop a system for extracting medication-related information from clinical text written in French. The hybrid system combining expert rules, contextual embeddings, and deep neural networks showed improved accuracy in medication information extraction, indicating synergy between expert and latent knowledge.

JMIR MEDICAL INFORMATICS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection

Justin Fortune Creeden et al.

Summary: The study suggests that the antidepressant fluoxetine may act as a potential therapy for hyperinflammatory states such as asthma, sepsis, and COVID-19 by targeting IL6ST and NF-kappaB Subunit 1 (NFKB1).

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study

Nicolas Hoertel et al.

Summary: The use of FIASMA medication in COVID-19 patients may reduce the risk of intubation or death, with this association remaining significant in multiple sensitivity analyses and not specific to a particular FIASMA class or medication. Double-blind controlled randomized clinical trials are needed to further investigate the potential benefits of these medications for COVID-19.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Letter Biochemistry & Molecular Biology

Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties

Emmanuel Stip et al.

MOLECULAR PSYCHIATRY (2021)

添加到收藏夹

Letter Biochemistry & Molecular Biology

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Nicolas Hoertel et al.

MOLECULAR PSYCHIATRY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

ORIGINAL RESEARCH Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021

Lyudmyla Kompaniyets et al.

Summary: This study identified that obesity, diabetes with complications, and anxiety disorders were the strongest risk factors for severe COVID-19 illness. Careful evaluation and management of underlying conditions among patients with COVID-19 can help reduce the risk of severe illness.

PREVENTING CHRONIC DISEASE (2021)

添加到收藏夹

Article Clinical Neurology

FLUOXETINE USE IS ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS WITH COVID-19 PNEUMONIA: A RETROSPECTIVE CASE-CONTROL STUDY

Zsofia Klara Nemeth et al.

Summary: This study investigated the association between fluoxetine use and survival in hospitalized COVID-19 pneumonia patients, finding that fluoxetine was associated with a significant decrease in mortality.

IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE (2021)

添加到收藏夹

Review Psychiatry

Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis

Benedetta Vai et al.

Summary: This systematic review and meta-analysis found that pre-existing mental disorders, specifically psychotic and mood disorders, and exposure to antipsychotics and anxiolytics were associated with an increased risk of COVID-19 mortality. The study highlighted the need for targeted approaches to manage and prevent COVID-19 in at-risk patient groups identified in this study. Further research is needed to determine the underlying mechanisms of these associations.

LANCET PSYCHIATRY (2021)

添加到收藏夹

Article Psychiatry

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Maxime Taquet et al.

Summary: Our study provides evidence of significant neurological and psychiatric morbidity in the 6 months following COVID-19 infection. The risks were highest in patients with severe COVID-19. This information could assist in service planning and research priority identification.

LANCET PSYCHIATRY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells

Alexander Carpinteiro et al.

Summary: The acid sphingomyelinase/ceramide system plays a crucial role in cellular infection with some viruses, including SARS-CoV-2. Ambroxol has the potential to inhibit acid sphingomyelinase and prevent SARS-CoV-2 infection, making it a candidate for clinical studies in preventing COVID-19.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

添加到收藏夹

Letter Critical Care Medicine

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Qiurong Ruan et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Letter Virology

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis

Francisco Alejandro Lagunas-Rangel

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Article Environmental Sciences

Disparities in the Use of General Somatic Care among Individuals Treated for Severe Mental Disorders and the General Population in France

Coralie Gandre et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

添加到收藏夹

Article Cell Biology

Prognosis analysis of patients with mental disorders with COVID-19: a single -center retrospective study

Yan Wan et al.

AGING-US (2020)

添加到收藏夹

Article Medicine, General & Internal

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta et al.

JAMA INTERNAL MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A stochastic agent-based model of the SARS-CoV-2 epidemic in France

Nicolas Hoertel et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Health Care Sciences & Services

COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State

Scott D. Landes et al.

DISABILITY AND HEALTH JOURNAL (2020)

添加到收藏夹

Letter Medicine, General & Internal

Association of a Prior Psychiatric Diagnosis With Mortality Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Infection

Luming Li et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Medicine, General & Internal

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial

Eric J. Lenze et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Cell Biology

Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells

Alexander Carpinteiro et al.

CELL REPORTS MEDICINE (2020)

添加到收藏夹

Article Geriatrics & Gerontology

Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis

Huazhen Yang et al.

LANCET HEALTHY LONGEVITY (2020)

添加到收藏夹

Article Psychiatry

COVID-19 and people with intellectual disability: impacts of a pandemic

K. Courtenay et al.

IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2020)

添加到收藏夹

Article Immunology

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine

Sebastian Schloer et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Article Cell Biology

Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis

Dorian A. Rosen et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Review Psychiatry

The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

Joseph Firth et al.

LANCET PSYCHIATRY (2019)

添加到收藏夹

Article Clinical Neurology

Network abnormalities in generalized anxiety pervade beyond the amygdala-pre-frontal cortex circuit: Insights from graph theory

Elena Makovac et al.

PSYCHIATRY RESEARCH-NEUROIMAGING (2018)

添加到收藏夹

Article Psychiatry

Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis

Elizabeth Reisinger Walker et al.

JAMA PSYCHIATRY (2015)

添加到收藏夹

Letter Substance Abuse

CORRELATION IS NO CAUSATION: GYMNASIUM PROLIFERATION AND THE RISK OF OBESITY

Yann Le Strat et al.

ADDICTION (2011)

添加到收藏夹

Article Substance Abuse

Increased Acid Sphingomyelinase Activity in Peripheral Blood Cells of Acutely Intoxicated Patients With Alcohol Dependence

Martin Reichel et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)

添加到收藏夹

Review Chemistry, Medicinal

The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments

Rodrigo Machado-Vieira et al.

PHARMACEUTICALS (2010)

添加到收藏夹

Article Medicine, General & Internal

The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies

Erik von Elm et al.

ANNALS OF INTERNAL MEDICINE (2007)

添加到收藏夹

Article Respiratory System

Anti-inflammatory properties of desipramine and fluoxetine

Caroline Roumestan et al.

RESPIRATORY RESEARCH (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.